Optima do Brasil is holding a Barrier Technology Seminar on March 11 and 12 in Vinhedo (São Paulo). The reason for this is the new regulations issued by the Brazilian health monitoring authority Anvisa on the use of barrier systems in pharmaceutical manufacturing. In specialist presentations, experts from Optima Pharma and Metall+Plastic will be providing information on barrier technologies such as isolators and RABS systems. The subjects of "Technology", "Project Handling" and "Real Application" will be discussed in depth in six workshops. Both companies have many years' experience in the fields of barrier technologies and filling technologies for pharmaceutical products.
"The Barrier Technology Seminar means we can provide our customers with the ideal platform, both for obtaining up-to-date information on the new Anivsa regulations and for familiarizing themselves with the latest barrier technologies," says Rolf Geissinger, Managing Director of Optima do Brasil. The seminar, which can be attended on March 11 or 12, covers all the information needed to prepare early for the new Anvisa regulations' requirements. The "RDC 301" regulation requires pharmaceutical companies to use barrier systems such as isolators or RABS to avoid contamination of the products.
Two days full of information and insights
In addition to specialist presentations on Anvisa regulation and the principles of barrier technology, the program will include six workshops in three different areas. The topic of "Technology" covers the introduction of products into the isolator or the RABS system. Matthias Aster, Team Leader Sales at Metall+Plastic, will be providing information about available isolator technologies. In the second unit of the workshop, experts will discuss how Optima Pharma's CSPE process cuts time-to-market. This is particularly important for pharma companies in South America: Using a project example, visitors will also learn how existing filling systems can be upgraded with RABS. The course ends with workshops on handling and cleaning from operating staff as well as procedures for bio-decontamination.
OPTIMA pharma and METALL+PLASTIC advise visitors to the Barrier Technology Seminar
Optima Pharma and Metall+Plastic provide support for upgrading existing filling lines or investment in new barrier systems. Metall+Plastic is a subsidiary of the Optima Pharma Division and has over 60 years of experience in the design, manufacturing, installation, qualification and validation of custom-made isolators. Metall+Plastic's achievements include the new STISO sterility test isolator and the award-winning DECOpulse® bio-decontamination system. Pharmaceutical filling and closing processes are designed and implemented as turnkey solutions in cooperation with Optima Pharma, including all upstream and downstream components.
Those interested can register to participate on March 11 or 12, 2020 at www.optima-packaging.com/barrier-tech.